Ronald E. Pauli
Direttore Finanziario/CFO presso BioQ Pharma, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Joshua Wilker Kriesel | M | - |
BioQ Pharma, Inc.
 BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Jeffrey W. Greve | M | 49 | 13 anni | |
| Patrick McIlvenny | M | 45 | 9 anni | |
| Mark J. Ehlert | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Llew Keltner | M | 74 |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Agnes Le Saux-Narjoz | F | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | 10 anni |
| Norvall Jasper | M | 77 |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Daniel Tassé | M | 64 |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Michael DesJardin | M | 66 | 8 anni | |
| Richard Nesbit | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Viscount Christopher Portman | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Christopher Vega | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | 12 anni |
| Ralph McNall | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | 11 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Albert Patterson | M | 80 |
Sagent Holdings Co.
 Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 6 anni |
| Jonathon Mark Singer | M | 60 | 6 anni | |
| Chen-Ming Yu | M | 50 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 7 anni |
| Bob Flanagan Flanagan | M | 67 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 7 anni |
| Aaron Cox | M | 41 | 7 anni | |
| Mary Taylor Behrens | F | 63 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 6 anni |
| Anthony Krizman | M | 67 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 6 anni |
| Marilyn Vetter | F | - | - | |
| Barry Moze | M | 70 | 8 anni | |
| Vikram Karnani | M | 49 | 9 anni | |
| Christine Cassiano | F | - |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 1 anni |
| Michael Logerfo | M | 59 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 4 anni |
| Paul Hoelscher | M | 59 | 8 anni | |
| Sheila Moran | F | 57 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 4 anni |
| Tom Moutvic | M | 62 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 4 anni |
| Brian Beeler | M | 51 | 9 anni | |
| James Shannon | M | 68 | 6 anni | |
| Dave Hebeda | M | 56 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 1 anni |
| Virinder Nohria | M | 70 | 3 anni | |
| Mary Martin | M | - | 1 anni | |
| Gino Santini | M | 67 | 11 anni | |
| Michael Grey | M | 71 | 12 anni | |
| H. Watkins | M | 71 | 9 anni | |
| Robert J. de Vaere | M | 66 | 6 anni | |
| William Daniel | M | 72 | 9 anni | |
| Lawrence Kenyon | M | 58 |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 6 anni |
| Jeff Yordon | M | 75 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 5 anni |
| Pascale Witz | F | 57 | 6 anni | |
| Michael Conick Hanley | M | 51 | 2 anni | |
| John J. Kody | M | - | 2 anni | |
| Sherri Stewart | F | - | 3 anni | |
| Ron Oyston | M | 54 | 3 anni | |
| Eric B. Mosbrooker | M | 46 | 2 anni | |
| Keli Walbert | F | - | - | |
| Richard Federer | M | - | - | |
| Tim Ayers | M | - | 3 anni | |
| Javier Szwarcberg | M | 54 | 1 anni | |
| Bradley Robinson | M | 55 | 2 anni | |
| Jeffrey Kent | M | 62 | - | |
| George Hampton | M | 54 | - | |
| Geoffrey M. Curtis | M | 49 | 8 anni | |
| Elizabeth Thompson | M | 49 | - | |
| Daniel Camardo | M | 55 | 7 anni | |
| Tina Ventura | F | - | - | |
| Shao Lee Lin | M | 57 | 2 anni | |
| Irina P. Konstantinovsky | F | 54 | 7 anni | |
| Lorin Drake | M | 71 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 5 anni |
| Ravi Malhotra | M | 81 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 5 anni |
| Miles W. McHugh | M | 59 | 8 anni | |
| Carlo Montagner | M | 56 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 1 anni |
| Amar P. Singh | M | 65 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 3 anni |
| Timothy Charles Melkus | M | 65 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 1 anni |
| Todd Smith | M | 55 | - | |
| Frank Kung | M | 75 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 5 anni |
| Patrick Ashe | M | 59 | - | |
| Leonard Shapiro | M | 96 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 5 anni |
| John Devane | M | - | - | |
| Keith S. Swenson | M | - | - | |
| Richard Maroun | M | 69 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 2 anni |
| John B. Thomas | M | - | 2 anni | |
| Steven Pfeiffer | M | 48 | 1 anni | |
| Shahid Ahmed | M | 71 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 5 anni |
| Margaret Foss | F | 68 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 3 anni |
| Scott W. Meacham | M | 64 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 2 anni |
| Daniel S. Robins | M | 57 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 2 anni |
| David Happel | M | 62 | 2 anni | |
| David Kelly | M | 63 | 4 anni | |
| Kirk Calhoun | M | 80 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 5 anni |
| Anthony Gulczynski | M | 66 |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | 5 anni |
| Mitchall G. Clark | M | 63 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | 4 anni |
| Robert Carey | M | 65 | 5 anni | |
| Michael Kelliher | M | 47 | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Irlanda | 45 | 52.94% |
| Stati Uniti | 40 | 47.06% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Ronald E. Pauli
- Contatti personali
